0.05Open0.05Pre Close0 Volume63 Open Interest4.00Strike Price0.00Turnover2914.95%IV25.39%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1621Delta0.3853Gamma64.60Leverage Ratio-4.6543Theta0.0000Rho10.47Eff Leverage0.0001Vega
Macrogenics Stock Discussion
f@#$%^&* up
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration With Incyte
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
No comment yet